Covalon Technologies Ltd (TSE:COV) Director Jeffrey Mandel sold 9,000 shares of the company’s stock in a transaction dated Thursday, September 7th. The stock was sold at an average price of C$2.99, for a total transaction of C$26,910.00.

Jeffrey Mandel also recently made the following trade(s):

  • On Wednesday, September 6th, Jeffrey Mandel sold 1,000 shares of Covalon Technologies stock. The stock was sold at an average price of C$2.99, for a total transaction of C$2,990.00.
COPYRIGHT VIOLATION NOTICE: “Jeffrey Mandel Sells 9,000 Shares of Covalon Technologies Ltd (COV) Stock” was first published by American Banking News and is owned by of American Banking News. If you are accessing this piece of content on another website, it was copied illegally and reposted in violation of United States & international copyright & trademark law. The original version of this piece of content can be read at https://www.americanbankingnews.com/2017/09/10/jeffrey-mandel-sells-9000-shares-of-covalon-technologies-ltd-cov-stock.html.

Covalon Technologies Company Profile

Covidien Public Limited Company is a healthcare products company. The Company is engaged in the development, manufacture and sale of healthcare products for use in clinical and home settings. The Company’s brands include Kendall, Nellcor, Puritan Bennett and Valleylab, among others. It has a presence in more than 70 countries, with products sold in over 150 countries.

Receive News & Ratings for Covalon Technologies Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Covalon Technologies Ltd and related companies with MarketBeat.com's FREE daily email newsletter.